ANEBULO PHARMACEUTICALS INC ANEB
COM · Common Stock · CUSIP 034569103
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersLakeway, TX
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 12 |
| Q4 2022 | 13 |
| Q1 2023 | 11 |
| Q2 2023 | 13 |
| Q3 2023 | 13 |
| Q4 2023 | 15 |
| Q1 2024 | 16 |
| Q2 2024 | 14 |
| Q3 2024 | 14 |
| Q4 2024 | 16 |
| Q1 2025 | 19 |
| Q2 2025 | 19 |
| Q3 2025 | 21 |
| Q4 2025 | 19 |
| Q1 2026 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2024 | 6 | 6 |
| Q3 2024 | 4 | 5 |
| Q4 2024 | 8 | 5 |
| Q1 2025 | 9 | 5 |
| Q2 2025 | 8 | 5 |
| Q3 2025 | 13 | 9 |
| Q4 2025 | 7 | 11 |
| Q1 2026 | 0 | 18 |
Biggest buyers
| None |
Biggest sellers
| 22NW, LP | Sold out | -15.5m |
| Nantahala Capital Management, LLC | Sold out | -3.0m |
| MANGROVE PARTNERS IM, LLC | Sold out | -2.5m |
| MORGAN STANLEY | Sold out | -399.4k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -160.8k |
| Rangeley Capital, LLC | Sold out | -50.0k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -25.1k |
| CITADEL ADVISORS LLC | Sold out | -24.2k |
| BlackRock, Inc. | Sold out | -23.8k |
| NORTHERN TRUST CORP | Sold out | -22.0k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| English Aron R. 13D · may seek influence no change · filed 2025-02-27 | 51.1% |
| Nantahala Capital Management, LLC 13G · institution -0.1 pts · filed 2026-02-13 | 8.5% |
| MANGROVE PARTNERS IM, LLC 13G · institution new · filed 2025-03-17 | 6.2% |
Insider purchases and sales in Q1 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
| Q4 2024 | 1 | $10.0m | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 0 | — | — |
| Q4 2025 | 0 | — | 0 | — | — |
| Q1 2026 | 0 | — | 0 | — | — |
None reported in Q1 2026.
Holders, Q1 2026
| Manager | Shares | Change |
|---|